jonathan Brown
Last active: 9/6/2016


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Differential role of an NF-κB transcriptional response element in endothelial versus intimal cell VCAM-1 expression. Milstone DS, Ilyama M, Chen M, O'Donnell P, Davis VM, Plutzky J, Brown JD, Haldar SM, Siu A, Lau AC, Zhu SN, Basheer MF, Collins T, Jongstra-Bilen J, Cybulsky MI (2015) Circ Res 117(2): 166-77
    › Primary publication · 26034041 (PubMed) · PMC4758452 (PubMed Central)
  2. NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis. Brown JD, Lin CY, Duan Q, Griffin G, Federation A, Paranal RM, Bair S, Newton G, Lichtman A, Kung A, Yang T, Wang H, Luscinskas FW, Croce K, Bradner JE, Plutzky J (2014) Mol Cell 56(2): 219-231
    › Primary publication · 25263595 (PubMed) · PMC4224636 (PubMed Central)
  3. Retinaldehyde dehydrogenase 1 deficiency inhibits PPARγ-mediated bone loss and marrow adiposity. Nallamshetty S, Le PT, Wang H, Issacsohn MJ, Reeder DJ, Rhee EJ, Kiefer FW, Brown JD, Rosen CJ, Plutzky J (2014) Bone : 281-91
    › Primary publication · 25064526 (PubMed) · PMC4209126 (PubMed Central)
  4. A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use. Liu S, Brown JD, Stanya KJ, Homan E, Leidl M, Inouye K, Bhargava P, Gangl MR, Dai L, Hatano B, Hotamisligil GS, Saghatelian A, Plutzky J, Lee CH (2013) Nature 502(7472): 550-4
    › Primary publication · 24153306 (PubMed) · PMC4141623 (PubMed Central)
  5. Deficiency of retinaldehyde dehydrogenase 1 induces BMP2 and increases bone mass in vivo. Nallamshetty S, Wang H, Rhee EJ, Kiefer FW, Brown JD, Lotinun S, Le P, Baron R, Rosen CJ, Plutzky J (2013) PLoS One 8(8): e71307
    › Primary publication · 23951127 (PubMed) · PMC3739807 (PubMed Central)